Hap Trading, LLC Esperion Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$2.02 - $3.02 $202,000 - $302,000	100,000 Added 80.0%	225,000 $309 Million
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $124,246 - $524,216	-170,200 Reduced 57.66%	125,000 $234 Million
Q2 2023 Aug 11, 2023	SELL	$1.2 - $1.76 $27,960 - $41,008	-23,300 Reduced 7.32%	295,200 $410,000
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $425,152 - $2.13 Million	291,200 Added 1066.67%	318,500 $37,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $138,957 - $232,050	27,300 New	27,300 $25,000
Q1 2022 May 12, 2022	SELL	$3.34 - $5.56 $49,766 - $82,844	-14,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $12,505 - $30,992	2,600 Added 21.14%	14,900 $3,000
Q3 2021 Nov 10, 2021	BUY	$11.34 - $21.37 $139,482 - $262,851	12,300 New	12,300 $15,000

206

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $147M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.